Abstract
Among the epithelial renal tumours with eosinophilic cytoplasm, the main differential diagnostic problem arises between renal oncocytomas (ROs) and eosinophilic variants of chromophobe renal cell carcinomas (RCCs). We investigated the possible role of anti-mitochondrial (AMA), anti-caveolin 1 (CAV1), anti-CD63 (CD63) and anti-cytokeratin 14 (CK14) antibodies in the differential diagnosis of eosinophilic epithelial tumours and applied the Muller and Mowry modification of Hale's colloidal iron stain (HCI). Thirty-five ROs and 77 eosinophilic RCCs (27 chromophobe, 28 clear cell and 22 papillary RCCs) were included in this study. Apical and/or polar CD63 immunostaining (94%) and diffuse AMA (91%) and CAV1 (88%) immunostainings were the characteristics of ROs, whereas diffuse CD63 immunostaining (96%) and diffuse-peripheral AMA (96%) and CAV1 (92%) immunostainings were characteristic immunohistochemical features of eosinophilic chromophobe RCCs. We showed CK14 antibody not to be useful in the differential diagnosis of the eosinophilic epithelial renal tumours. The staining localisations with AMA, CAV1 and CD63 antibodies were significantly different between tumour groups. AMA had 96% sensitivity and 94% specificity, whereas CAV1 had 92% sensitivity and 97% specificity in diagnosing chromophobe RCCs. With HCI staining, ROs, showing apical and/or polar staining, could be differentiated from chromophobe RCCs, showing diffuse cytoplasmic staining. HCI had fairly low (69%) sensitivity and 100% specificity, whereas CD63 had 95% sensitivity and 100% specificity to diagnose ROs. We recommend using CD63 as the best marker of choice for distinguishing ROs from eosinophilic chromophobe RCCs when standard diagnostic criteria are not helpful.
Similar content being viewed by others
References
Abrahams NA, MacLennan GT, Khoury JD et al (2004) Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 45:593–602
Akhtar M, Kardar H, Linjawi T et al (1995) Chromophobe cell carcinoma of the kidney: a clinicopathologic study of 21 cases. Am J Surg Pathol 19:1245–1256
Amin MB, Amin MB, Tamboli P et al (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26:281–291
Amin MB, Crotty TB, Tickoo SK et al (1997) Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21:1–12
Avery AK, Beckstead J, Renshaw AA et al (2000) Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 24:203–210
Bancroft JD, Gamble M (eds) (2002) Theory and practice of histological techniques, 5th edn. Churchill Livingstone, Edinburgh
Barnes CA, Beckman EN (1983) Renal oncocytoma and its congeners. Am J Clin Pathol 79:312–318
Bonsib SM (1996) Renal chromophobe cell carcinoma: the relationship between cytoplasmic vesicles and colloidal iron stain. J Urol Pathol 4:9–14
Bonsib SM, Bray C, Timmerman TG (1993) Renal chromophobe cell carcinoma: limitations of paraffin-embedded tissue. Ultrastruct Pathol 17:529–536
Bonsib SM, Larger D (1990) Chromophobe cell carcinoma: analysis of five cases. Am J Surg Pathol 14:260–267
Carrion R, Morgan BE, Tannenbaum M et al (2003) Caveolin expression in adult renal tumors. Urol Oncol 21:191–196
Cheville JC, Lohse CM, Zincke H et al (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624
Chu PG, Lyda MH, Weiss LM (2001) Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours. Histopathology 39:9–16
Chu PG, Weiss LM (2001) Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases. Histopathology 39:455–462
Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms. Histopathology 40:403–439
Cochand-Priollet B, Molinie V, Bougaran J et al (1997) Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch Pathol Lab Med 121:1081–1086
Eble JN, Amin MB, Young RH (1997) Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol 21:1123–1130
Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) World Health Organization classification of tumours. Pathology and genetics of the urinary system and male genital organs. IARC, Lyon
Erlandson RA, Shek TWH, Reuter VE (1997) Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors. Ultrastruct Pathol 21:409–417
Gartner LP, Hiatt JL (eds) (2001) Color textbook of histology, 2nd edn. WB Saunders, Philadelphia
Hagen EC, Vennegoor C, Schlingemann RO et al (1986) Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections. Histopathology 10:689–700
Juhasz M, Chen J, Tulassay Z et al (2003) Expression of caveolin-1 in gastrointestinal and extraintestinal cancers. J Cancer Res Clin Oncol 129:493–497
Khoury JD, Abrahams NA, Levin HS et al (2002) The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann Diagn Pathol 6:154–158
Langner C, Wegscheider BJ, Ratschek M et al (2004) Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors. Virchows Arch 444:127–134
Leroy X, Mouskassa D, Copin MC et al (2000) Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal cell carcinoma. Eur Urol 37:484–487
Li S, Couet J, Lisanti MP (1996) Src tyrosine kinases, G alpha subunits, and H-ras share a common membrane-anchored scaffolding protein caveolin: caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271:29182–29190
Li WP, Liu P, Anderson RG (2001) Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J Cell Sci 114:1397–1408
Liu J, Fanning CV (2001) Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? Cancer 93:390–397
Mackie RM, Campbell I, Turbitt ML (1984) Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol 37:367–372
Martignoni G, Pea M, Chilosi M et al (2001) Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 14:760–767
Mathers ME, Pollock AM, Marsh C et al (2002) Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 563–567
Metzelaar MJ, Wijngaard PL, Peters PJ et al (1991) A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 266:3239–3245
Miettinen M, Ekfors T (1990) Alveolar soft part sarcoma. Immunohistochemical evidence for muscle cell differentiation. Am J Clin Pathol 93:32–38
Murphy WM, Beckwith JB, Farrow GM (1994) Tumors of the kidney, bladder and related urinary structures. In: Rosai J (ed) Atlas of Tumor Pathology, 3rd series, fascicle 11. Armed Forces Institute of Pathology, Washington, DC
Ordonez NG, Rosai J (2004) Urinary tract: kidney, renal pelvis and ureter. In: Rosai J (ed) Rosai and Ackerman's surgical pathology, vol 1, 9th edn. Mosby, Edinburgh, pp 1163–1316
Palmer AA, Hall BE, Lew M (1985) A comparison of some methods for identifying melanotic and amelanotic melanoma metastases in paraffin sections. Pathology 17:335–339
Perez-Ordonez B, Hamed G, Campbell S et al (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21:871–883
Porena M, Vespasiani G, Rosi P et al (1992) Incidentally detected renal cell carcinoma: role of ultrasonography. J Clin Ultrasound 20:395–400
Renshaw AA (2002) Subclassification of renal cell neoplasms: an update for practising pathologist. Histopathology 41:283–300
Robenek MJ, Schlattmann K, Zimmer KP et al (2003) Cholesterol transporter caveolin-1 transits the lipid bilayer during intracellular cycling. FASEB J 17:1940–1942
Romis L, Cindolo L, Patard JJ et al (2004) Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol 45:53–57
Rothberg KG, Heuser JE, Donzell WC et al (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68:673–682
Rous BA, Reaves BJ, Ihrke G et al (2002) Role of adaptor complex AP-3 in targeting wild type and mutated CD63 to lysosomes. Mol Biol Cell 13:1071–1082
Skinnider BF, Jones EC (1999) Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy. Am J Clin Pathol 111:796–803
Stoller ML, Carroll PR (2003) Urology. In: Tierney LM, McPhee SJ, Papadakis MA (eds) Current medical diagnosis & treatment 2003, 42nd edn. Lange Medical Books/McGraw-Hill, New York, pp 903–945
Stone CH, Lee MW, Amin MB et al (2001) Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med 125:751–758
Störkel S, Steart PV, Drenckhahn D et al (1989) The human chromophobe cell renal cell carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol 56:237–245
Thoenes W, Baum HP, Störkel S et al (1987) Cytoplasmic microvesicles in chromophobe cell renal carcinoma demonstrated by freeze fracture. Short communication. Virchows Arch B Cell Pathol Incl Mol Pathol 54:127–130
Thoenes W, Störkel S, Rumpelt HJ (1985) Human chromophobe cell renal carcinoma. Virchows Arch B Pathol 48:207–217
Thoenes W, Störkel S, Rumpelt HJ et al (1988) Chromophobe cell renal carcinoma and its variants: a report on 32 cases. J Pathol 155:277–287
Tickoo SK, Amin MB, Linden MD et al (1997) Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. Am J Surg Pathol 21:922–930
Tickoo SK, Amin MB, Zarbo RJ (1998) Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma. Emphasis on technique and patterns of staining. Am J Surg Pathol 22:419–424
Tickoo SK, Lee MW, Eble JN et al (2000) Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol 24:1247–1256
Vennegoor C, Calafat J, Hageman P et al (1985) Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C3. Int J Cancer 35:287–295
Vieillefond A, Paradis V, Bouvier GR et al (1992) Est-il utile d'isoler parmi les carcinomes du rein, une variante a cellules chromophobes? Arch Anat Cytol Pathol 40:250–254
Wanaski SP, Glaser BK, Glaser M (2003) Caveolin scaffolding region and the membrane binding region of Src form lateral membrane domains. Biochemistry 42:42–56
Weiss LM, Gaffey MJ, Warhol MJ (1991) Immunohistochemical characterization of a monoclonal antibody directed against mitochondria reactive in paraffin-embedded sections. Mod Pathol 4:596–601
Wu SL, Kothari P, Wheeler TM et al (2002) Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and oncocytomas. Mod Pathol 15:712–717
Acknowledgements
This work was supported by the Research Fund of Istanbul University (Project number: T-332/03112003). The authors would also to thank Dr. N. Büyükbabani (Department of Pathology, Istanbul Faculty of Medicine, Istanbul University) for his observations about CD63.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mete, O., Kilicaslan, I., Gulluoglu, M.G. et al. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch 447, 938–946 (2005). https://doi.org/10.1007/s00428-005-0048-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-005-0048-6